Autopsy report · NCT00151294
The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis
Cause of deathNo reason given
Life of this trial
- Registered 10 months after it had already started.
- Ran for about 1 year 11 months before it stopped.
- 20 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Conditions
- Depression; Multiple Sclerosis
- Interventions
- escitalopram oxalate antidepressant
- Participants
- 20
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.